Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNovel Multimodality & Nonradioactive Probes

Dual-modality imaging of peptide M2pep modified nanomicelle targeting tumor associated macrophages

MingXing Huang, Rang Wang, Mufeng Li and Rong Tian
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 2826;
MingXing Huang
1Department of Nuclear Medicine, West China Hospital, Sichuan University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rang Wang
1Department of Nuclear Medicine, West China Hospital, Sichuan University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mufeng Li
1Department of Nuclear Medicine, West China Hospital, Sichuan University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rong Tian
1Department of Nuclear Medicine, West China Hospital, Sichuan University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

2826

Introduction: Tumor associated macrophages (TAMs) constitute a significant part in the tumor microenvironment and are classified into M1 and M2 macrophages. Among these, M2 TAMs can promote tumor progression and distal metastasis by degrading tumor extracellular matrix, promoting tumor angiogenesis, and recruiting immunosuppressive cells. Therefore, M2 TAMs have been considered a favorable target to cancer diagnosis and therapy. Herein, a nanomicelle targeting M2 TAMs was synthesized to co-deliver radionuclide and superparamagnetic iron (SPIO) to the tumor site for dual-modality imaging.

Methods: M2pep, a peptide ligand selectively binding to M2 TAMs, was coated on DSPE-PEG micelle via surface modification, which also conjugated radionuclides by a chelator DOTA and encapsulated the MRI contrast agent SPIO. The capability of nanomicelle to target M2 TAMs was assessed in vitro. We also investigated the imaging features by melanoma B16-F10 mouse models undergoing MRI and PET/CT imaging

Results: We chose 68Ga as a radionuclide to conjugate DSPE-PEG nanomicelle encapsulated SPIO. Radiochemical purity over 90% was achieved. 68Ga labelled nanomicelle with M2pep showed a higher cellular binding rate than those without M2pep. MRI findings showed accumulation of M2pep modified nanomicelle on the tumor site, and MRI signal decreased 23.93±2.71% and 30.23±8.87% at 1h and 4h post-injection, respectively. In Micro-PET/CT scanning, the uptake was deposited in the B16-F10 tumor at 1h post-injection 68Ga labelled nanomicelle with M2pep (Figure 1). The tumor/muscle ratio increased from 5.1 at 1h to 8.4 at 4h.

Conclusions: Our results confirm that M2pep modified nanomicelle provides a promising method for specific M2 TAMs dual-modality imaging. Further, we also can develop a M2pep modified therapeutic nanomicelle by using therapeutic radionuclides and drugs to replace 68Ga and SPIO, which provides a potential strategy to inhibit tumor growth and metastasis.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Dual-modality imaging of peptide M2pep modified nanomicelle targeting tumor associated macrophages
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Dual-modality imaging of peptide M2pep modified nanomicelle targeting tumor associated macrophages
MingXing Huang, Rang Wang, Mufeng Li, Rong Tian
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2826;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Dual-modality imaging of peptide M2pep modified nanomicelle targeting tumor associated macrophages
MingXing Huang, Rang Wang, Mufeng Li, Rong Tian
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2826;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Nanostructured Polyvinylpyrrolidone-Curcumin Conjugates allowed for Kidney-targeted Treatment of Cisplatin Induced Acute Kidney Injury
  • Open-shell Nanosensitizers for Glutathione Responsive Cancer Sonodynamic Therapy
Show more Novel Multimodality & Nonradioactive Probes

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire